Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) Presented Preclinical Data on GNTbm-38, an Novel Epigenetic Immune Activator, at the 2025 ASCO Annual Meeting 2025-05-23 08:00
1